Valuation (16%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 0.00 | -18.94 |
PEG Ratio (TTM) | N/A | -5.61 |
P/S Ratio (TTM) | 324.77 | 47.90 |
P/B Ratio (TTM) | 0.70 | 30.89 |
P/FCF Ratio (TTM) | 0.00 | -6.05 |
Price to 5YR AVG Earnings Ratio | -0.13 | -5.69 |
Price to 5YR AVG FCF Ratio | -0.39 | -13.62 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -23,587.96% | -17.89% |
ROE (TTM) | -26,438.24% | 28.85% |
Net Profit Margin (TTM) | -12,414,736.82% | -540.96% |
ROIC 5YR AVG | -90.91% | -3.04% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -18,757.97% | -438.10% | -247.77% |
Revenue | -68.39% | -27.44% | 60.80% |
Net Income | -19,491.27% | -48.24% | -17.18% |
Cash Flow | -74,728.33% | -45.38% | -18.78% |
Health (18%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.88 | 5.75 |
Quick Ratio (TTM) | 0.20 | 5.53 |
D/E Ratio (TTM) | 169.23 | 1.08 |
Interest Coverage (TTM) | -259.53 | -7.40 |
Piotroski F-Score | 3 | 5 |
Altman Z-Score | N/A | 13.03 |
LTL to 5YR AVG FCF | -0.07 | 0.08 |
Shares Outstanding Growth 5YR AVG | 5.29% | 40.65% |